Herrman, Marissa; Mühe, Janine; Quink, Carol et al. (2016) Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques. J Virol 90:1222-30
|
Mühe, Janine; Wang, Fred (2015) Host Range Restriction of Epstein-Barr Virus and Related Lymphocryptoviruses. J Virol 89:9133-6
|
Griffin, Bryan D; Gram, Anna M; Mulder, Arend et al. (2013) EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol 190:1672-84
|
Wang, Fred (2013) Nonhuman primate models for Epstein-Barr virus infection. Curr Opin Virol 3:233-7
|
Fogg, Mark; Murphy, John R; Lorch, Jochen et al. (2013) Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma. Virology 441:107-13
|
Ohashi, Makoto; Fogg, Mark H; Orlova, Nina et al. (2012) An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection. PLoS Pathog 8:e1003095
|
Kawabata, Thomas; Weaver, James; Thomas, Dolca et al. (2012) Summary of roundtable discussion meeting: non-human primates to assess risk for EBV-related lymphomas in humans. J Immunotoxicol 9:121-7
|
Ohashi, Makoto; Orlova, Nina; Quink, Carol et al. (2011) Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene. J Virol 85:1330-9
|
Fogg, Mark H; Wirth, Lori J; Posner, Marshall et al. (2009) Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 106:3318-23
|
Rivailler, Pierre; Kaur, Amitinder; Johnson, R Paul et al. (2006) Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus. J Virol 80:4179-82
|
Showing the most recent 10 out of 26 publications